138 related articles for article (PubMed ID: 21749382)
1. Supersaturated dissolution data and their interpretation: the TPGS-carbamazepine model case.
Charkoftaki G; Dokoumetzidis A; Valsami G; Macheras P
J Pharm Pharmacol; 2011 Mar; 63(3):352-61. PubMed ID: 21749382
[TBL] [Abstract][Full Text] [Related]
2. Solubilization of Carbamazepine in TPGS Micelles: Effect of Temperature and Electrolyte Addition.
Jain S; Pandey S; Sola P; Pathan H; Patil R; Ray D; Aswal VK; Bahadur P; Tiwari S
AAPS PharmSciTech; 2019 May; 20(5):203. PubMed ID: 31139965
[TBL] [Abstract][Full Text] [Related]
3. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
4. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate.
Jin F; Tatavarti A
Int J Pharm; 2010 Apr; 389(1-2):58-65. PubMed ID: 20083178
[TBL] [Abstract][Full Text] [Related]
5. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781.
Goddeeris C; Willems T; Van den Mooter G
Eur J Pharm Sci; 2008 Aug; 34(4-5):293-302. PubMed ID: 18602800
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method.
Sethia S; Squillante E
J Pharm Sci; 2002 Sep; 91(9):1948-57. PubMed ID: 12210042
[TBL] [Abstract][Full Text] [Related]
7. Physical and dissolution characterization of cilostazol solid dispersions prepared by hot melt granulation (HMG) and thermal adhesion granulation (TAG) methods.
Chen YC; Ho HO; Chiou JD; Sheu MT
Int J Pharm; 2014 Oct; 473(1-2):458-68. PubMed ID: 25089508
[TBL] [Abstract][Full Text] [Related]
8. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
9. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release.
Milović M; Djuriš J; Djekić L; Vasiljević D; Ibrić S
Int J Pharm; 2012 Oct; 436(1-2):58-65. PubMed ID: 22721847
[TBL] [Abstract][Full Text] [Related]
10. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies.
Eedara BB; Veerareddy PR; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2014 Aug; 40(8):1030-43. PubMed ID: 23738504
[TBL] [Abstract][Full Text] [Related]
11. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
Goddeeris C; Van den Mooter G
Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
[TBL] [Abstract][Full Text] [Related]
12. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
[TBL] [Abstract][Full Text] [Related]
13. Enhanced solubility and oral absorption of sirolimus using D-α-tocopheryl polyethylene glycol succinate micelles.
Kim MS; Kim JS; Cho WK; Hwang SJ
Artif Cells Nanomed Biotechnol; 2013 Apr; 41(2):85-91. PubMed ID: 23305536
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization of solid dispersion of furosemide with TPGS.
Shin SC; Kim J
Int J Pharm; 2003 Jan; 251(1-2):79-84. PubMed ID: 12527177
[TBL] [Abstract][Full Text] [Related]
15. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.
Goddeeris C; Willems T; Houthoofd K; Martens JA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):861-8. PubMed ID: 18691650
[TBL] [Abstract][Full Text] [Related]
16. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
Tayel SA; Soliman II; Louis D
Eur J Pharm Biopharm; 2008 May; 69(1):342-7. PubMed ID: 17949959
[TBL] [Abstract][Full Text] [Related]
17. Processing challenges with solid dosage formulations containing vitamin E TPGS.
Pandey P; Sinko PD; Bindra DS; Hamey R; Gour S; Vema-Varapu C
Pharm Dev Technol; 2013 Feb; 18(1):296-304. PubMed ID: 23136832
[TBL] [Abstract][Full Text] [Related]
18. Increased dissolution rates of carbamazepine--gluconolactone binary blends processed by hot melt extrusion.
Moradiya HG; Nokhodchi A; Bradley MS; Farnish R; Douroumis D
Pharm Dev Technol; 2016; 21(4):445-52. PubMed ID: 25757644
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.
Ha ES; Ok J; Noh J; Jeong HY; Choo GH; Jung YS; Baek IH; Kim JS; Cho W; Hwang SJ; Kim MS
Int J Biol Macromol; 2015 Jan; 72():1473-8. PubMed ID: 25451745
[TBL] [Abstract][Full Text] [Related]
20. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]